about
Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a reviewBurden of obstructive lung disease study in Tehran: Prevalence and risk factors of chronic obstructive pulmonary diseasePathogenesis and treatment of skin lesions caused by sulfur mustard.Investigating Prevalence and Pattern of Long-term Cardiovascular Disorders in Sulphur Mustard-exposed Victims and Determining Proper Biomarkers for Early Defining, Monitoring and Analysis of Patients' Feedback on Therapy.Mustard gas exposure and carcinogenesis of lung.Prevalence of tobacco use and associated factors in Tehran: Burden of Obstructive Lung Disease study.Low Levels of Extensively Drug-resistant Tuberculosis among Multidrug Resistant Tuberculosis Isolates and Their Relationship to Risk Factors: Surveillance in Tehran, Iran; 2006 to 2014.Pathway reconstruction of airway remodeling in chronic lung diseases: a systems biology approach.Microarray gene expression analysis of the human airway in patients exposed to sulfur mustard.Comparative proteome analysis of peripheral neutrophils from sulfur mustard-exposed and COPD patients.Characterization of Lung Fibroblasts More than Two Decades after Mustard Gas ExposureThe Social Determinants of Health in Military Forces of Iran: A Qualitative Study.Proteomic analysis of drug-resistant Mycobacterium tuberculosis by one-dimensional gel electrophoresis and charge chromatography.Determination of Characteristics of Erythromycin Resistant Streptococcus pneumoniae with Preferred PCV Usage in Iran.A Triage Model for Chemical Warfare Casualties.Encapsulation of alpha-1 antitrypsin in PLGA nanoparticles: in vitro characterization as an effective aerosol formulation in pulmonary diseases.Combination therapy for airflow limitation in COPD.Exertional-induced bronchoconstriction: comparison between cardiopulmonary exercise test and methacholine challenging testA Proposed Strategy for Research Misconduct Policy: A Review on Misconduct Management in Health Research SystemLung carcinogenicity of sulfur mustard.Mustard gas toxicity: the acute and chronic pathological effects.Sulfur mustard toxicity: history, chemistry, pharmacokinetics, and pharmacodynamics.Clinical and paraclinical guidelines for management of sulfur mustard induced bronchiolitis obliterans; from bench to bedside.The role of N-acetylcysteine in the management of acute and chronic pulmonary complications of sulfur mustard: a literature review.Plasma proteomic profile of sulfur mustard exposed lung diseases patients using 2-dimensional gel electrophoresis.Role of oxidative stress in sulfur mustard-induced pulmonary injury and antioxidant protection.Molecular mechanisms of curcumins suppressing effects on tumorigenesis, angiogenesis and metastasis, focusing on NF-κB pathway.miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer.Overexpression of the non-coding SOX2OT variants 4 and 7 in lung tumors suggests an oncogenic role in lung cancer.Identification of new SOX2OT transcript variants highly expressed in human cancer cell lines and down regulated in stem cell differentiation.Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors.A novel dendritic cell-targeted lentiviral vector, encoding Ag85A-ESAT6 fusion gene of Mycobacterium tuberculosis, could elicit potent cell-mediated immune responses in mice.Airway remodeling: Systems biology approach, from bench to bedside.Proteome-scale MDR-TB-antibody responses for identification of putative biomarkers for the diagnosis of drug-resistant Mycobacterium tuberculosis.TGF-β and Th17 Cells Related Injuries in Patients with Sulfur Mustard Exposure.Correlations of sleep disorders with severity of obstructive airway disease in mustard gas-injured patients.Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication.Efficacy and safety of aluminum chloride in controlling external hemorrhage: an animal model study.Frequency distribution of gastro esophageal reflux disease in inhalation injury: A historical cohort study.T cell cytokine responses in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis following stimulation with proteins purified from Mycobacterium tuberculosis MDR clinical isolates.
P50
Q28390078-5EA87A5D-8F17-4332-B1F1-1F0E04ECC3B7Q28606967-5413869B-F38C-47DB-8AB6-A5CAC373F681Q30224878-950204AA-006B-4471-A859-8503B2FD0F31Q30245541-93175763-0FA0-4177-9B10-407DB2DF36F0Q33612018-78D97AB3-46A4-4F57-91AE-BB7B88A85A0AQ33668561-9F84212B-371D-4D2A-B6FC-83B3CE9C0BDDQ33718580-B8158F8D-16FF-4C77-BCDF-95B3062DF92BQ33827775-2334D7EC-64C2-46BB-A28A-B31B1513F44DQ34419796-3E904D42-73D6-4237-A2D8-970085B25C78Q35172484-E7B19B37-B79B-48E2-BE14-FB8DC1C04F6CQ35872285-92D130E9-5275-4067-8800-D560E82FCEE5Q36031981-A84A7683-7BE7-4E0C-B8AE-3302D48B6786Q36078099-982DB7B7-486D-4AE9-AAEB-C7D784CB3FB2Q36235582-D9A636D1-C70C-4875-A8AA-27CBAC0E6FCFQ36242027-E1F145EF-ED4C-453A-808B-5ECBE45457FEQ36360151-865F1DDE-781F-4F7A-ACE1-E3538A624DD7Q36445725-715ECA58-812E-426B-B4DF-53ACFB696B79Q36939557-ABF8A2B3-D456-4FD7-BD61-C20853D86F61Q37137648-BA77C9B0-3ADD-4BB7-B86F-E6763534942FQ37677881-871F85E8-E326-414F-8159-43CB67845130Q37788087-0CFAED8B-FBBA-4144-91BD-C27306BF74FEQ37844161-37012039-CB1D-4535-960B-732293E94F7DQ38057375-C47DE692-9DA2-4E31-AE87-5C7381D90693Q38233230-6EA1C79D-1ECB-4D9C-91EA-EF2B6F5CA3ACQ38310935-6A5A1ED2-5BC5-460D-93DC-6AECFDB91675Q38601927-7233F2C1-E9C1-4C71-B345-FCBAA3D85BD0Q38698935-37A339FD-D0F1-4419-9F50-27EAF9377819Q38709462-47729EE5-A5D8-4F72-B8A9-A19F88D5A329Q38796631-FA9EB6C1-8397-47E8-8D9F-F2B735388F8AQ38809176-C767B41E-B839-4C14-86E2-85CBFC121603Q38813954-61782CF9-A242-444C-A550-89F952FD423DQ38857600-278C65B0-0B2B-46DC-8950-6934E5F1AA1AQ38868441-96883FD1-6D52-46E6-A6E3-D0308EFBBCD8Q39044160-6BCC660A-C2BE-4BA5-A1A4-4AF460FE99D3Q39408352-1F87C607-0680-4FA2-9069-DCDCEF403034Q39754663-0920B6CD-15A6-4AB6-8181-C6A6FD4FBB96Q39934972-E76C9995-8A73-449D-8425-A4F8CF0A5B1FQ40186699-283BD4A0-0509-4B3D-B3B4-4EF86404686CQ40258061-47D8F845-C8D9-4D02-B5EA-E02B653B909FQ40399164-C0FCE427-0915-4D58-985D-FC925C783245
P50
description
investigador
@es
researcher
@en
name
Mostafa Ghanei
@en
Mostafa Ghanei
@nl
type
label
Mostafa Ghanei
@en
Mostafa Ghanei
@nl
prefLabel
Mostafa Ghanei
@en
Mostafa Ghanei
@nl
P31
P496
0000-0001-9372-0928